Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses

By Judge Heather M.   Buckland Robert J.   Holgate Carol E.   Storey Robert F.  

Platelets, Vol. 16, Iss. 7, 2005-11 ,pp. : 398-407

Informa Healthcare

Access to resources Recommend Favorite

Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel

By Hermann Alexander   Rauch Bernhard H.   Braun Marina   Schrör Karsten   Weber Artur-Aron  

Platelets, Vol. 12, Iss. 2, 2001-03 ,pp. : 74-82

Informa Healthcare

Access to resources Recommend Favorite

Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets

By Reinboldt Stephan   Wenzel Folker   Rauch Bernhard   Hohlfeld Thomas   Grandoch Maria   Fischer Jens   Weber Artur-Aron  

Platelets, Vol. 20, Iss. 6, 2009-09 ,pp. : 441-444

Informa Healthcare

Access to resources Recommend Favorite

CD40-CD40L Interactions in Atherosclerosis

By Lutgens E.   Daemen M.J.A.P.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 1, 2002-01 ,pp. : 27-32

Elsevier

Access to resources Recommend Favorite

Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation

By Yngen M.   Östenson C.-G.   Hu H.   Li N.   Hjemdahl P.   Wallén N.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 537-540

Springer Publishing Company

Access to resources Recommend Favorite